Differential effects of specific amino acid restriction on glucose metabolism, reduction/oxidation status and mitochondrial damage in DU145 and PC3 prostate cancer cells

Oncology Letters

Volumn 2, Issue 2, 2011, Pages 349-355

  Liu, Xiaoyi ^a   Fu, Ya Min ^a   Meadows, Gary G ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Amino acid dependency; Glucose metabolism; Mitochondrial damage; Oxidative stress; Prostate cancer

Indexed keywords

AMINO ACID; GLUCOSE; GLUTAMINE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LACTIC ACID; MANGANESE SUPEROXIDE DISMUTASE; METHIONINE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PHENYLALANINE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TYROSINE;

APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; FLOW CYTOMETRY; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; MITOCHONDRION; OXIDATION REDUCTION STATE; PROSTATE CANCER;

EID: 79551634068     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.237     Document Type: Article

References (18)

1. Tenniswood M: Apoptosis, tumour invasion and prostate cancer. Br J Urol 79: 27-34, 1997.
2. Denmeade SR, Isaacs JT, August JT, et al: Activation of programmed (apoptotic) cell death for the treatment of prostate cancer. In: Advances in Pharmacology (Vol 35). Academic Press, Inc., San Diego, CA, pp281-305, 1996.
3. Fu YM, Yu ZX, Li YQ, et al: Specific amino acid dependency regulates invasiveness and viability of androgen-independent prostate cancer cells. Nutr Cancer 45: 60-73, 2003.
4. Fu YM, YU ZX, Lin H, Fu X and Meadows GG: Selective amino acid restriction differentially affects the motility and directionality of DU145 and PC3 prostate cancer cells. J Cell Physiol 217: 184-193, 2008.
5. Fu YM, Zhang H, Ding M, et al: Selective amino acid restriction targets mitochondria to induce apoptosis of androgen-indepen- dent prostate cancer cells. J Cell Physiol 209: 522-534, 2006.
6. Green DR and Reed JC: Mitochondria and apoptosis. Science 281: 1309-1312, 1998.
7. Fu YM, Yu ZX, Pelayo BA, et al: Focal adhesion kinase- dependent apoptosis of melanoma induced by tyrosine and phenylalanine deficiency. Cancer Res 59: 758-765, 1999.
8. Nemoto S, Takeda K, Yu ZX, et al: Role for mitochondrial oxidants as regulators of cellular metabolism. Mol Cell Biol 20: 7311-7318, 2000.
9. Balaban RS, Nemoto S and Finkel T: Mitochondria, oxidants, and aging. Cell 120: 483-495, 2005.
10. Arbiser JL: Molecular regulation of angiogenesis and tumori- genesis by signal transduction pathways: evidence of predictable and reproducible patterns of synergy in diverse neoplasms. Semin Cancer Biol 14: 81-91, 2004.
11. Wallace DC: Mitochondrial diseases in man and mouse. Science 283: 1482-1488, 1999.
12. Galluzzi L, Larochette N, Zamzami N, et al: Mitochondria as therapeutic targets for cancer chemotherapy. Oncogene 25: 4812-4830, 2006.
13. Matoba S, Kang JG, Patino WD, et al: p53 regulates mitochondrial respiration. Science 312: 1650-1653, 2006.
14. Benlloch M, Mena S, Ferrer P, et al: Bcl-2 and Mn-SOD antisense oligodeoxynucleotides and a glutamine-enriched diet facilitate elimination of highly resistant B16 melanoma cells by tumor necrosis factor-alpha and chemotherapy. J Biol Chem 281: 69-79, 2006.
15. Fu YM, Lin H, Liu X,: Cell death of prostate cancer cells by specific amino acid restriction depends on alterations of glucose metabolism. J Cell Physiol 224: 491-500, 2010.
16. Weber G: Ordered biochemical program of gene expression in cancer cells. Biochemistry 66: 1164-1173, 2001.
17. Petros JA, Baumann AK, Ruiz-Pesini E, et al: mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 102: 719-724, 2005.
18. Carew JS and Huang P: Mitochondrial defects in cancer. Mol Cancer 1: 9, 2002.